FGFR2 N549K
|
Gastric Cancer
|
FGFR2 N549K
|
Gastric Cancer
|
TAS 120 Sensitive: D – Preclinical
|
TAS 120 Sensitive: D – Preclinical
|
FGFR2 N549K
|
Endometrial Cancer
|
FGFR2 N549K
|
Endometrial Cancer
|
TAS 120 Sensitive: D – Preclinical
|
TAS 120 Sensitive: D – Preclinical
|
FGFR2 N549K
|
Endometrial Cancer
|
FGFR2 N549K
|
Endometrial Cancer
|
TAS 120 + TAS-117 Sensitive: D – Preclinical
|
TAS 120 + TAS-117 Sensitive: D – Preclinical
|
FGFR2 N549K
|
Endometrial Cancer
|
FGFR2 N549K
|
Endometrial Cancer
|
TAS 120 + MK-2206 Sensitive: D – Preclinical
|
TAS 120 + MK-2206 Sensitive: D – Preclinical
|
FGFR2 N549K
|
Endometrial Cancer
|
FGFR2 N549K
|
Endometrial Cancer
|
ponatinib Sensitive: D – Preclinical
|
ponatinib Sensitive: D – Preclinical
|
FGFR2 N549K
|
Endometrial Cancer
|
FGFR2 N549K
|
Endometrial Cancer
|
RLY-4008 Sensitive: D – Preclinical
|
RLY-4008 Sensitive: D – Preclinical
|